Diclofenac derivatives as promising anticancer and anti-inflammatory drug: Synthesis, formulations, and pharmacokinetics

被引:3
|
作者
Alshargabi, Arwa [1 ,2 ]
机构
[1] Saba Univ, Fac Med Sci, Pharm Dept, Sanaa, Yemen
[2] Al Nasser Univ, Fac Med & Hlth Sci, Dept Pharm, Sanaa, Yemen
关键词
Diclofenac; Nanoparticle; Anti-inflammatory; Drug release; Anticancer; IN-VITRO CHARACTERIZATION; PHARMACOLOGICAL EVALUATION; METABOLIC-ACTIVATION; MOLECULAR-MECHANISMS; TRANSDERMAL DELIVERY; ACYL GLUCURONIDE; SKIN PERMEATION; VIVO EVALUATION; ELLAGIC ACID; SODIUM;
D O I
10.1016/j.jddst.2024.105544
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diclofenac (DCF) is well-known non-steroidal anti-inflammatory drug used in the treatment of several cancer cell lines. DCF is derived from phenylacetic acid, and its pharmaceutical activity is attributed to the carboxylic acid moiety. The carboxylic acid group is also responsible for the DCF's side effects, which include gastrointestinal bleeding and ulceration. Therefore, researchers do vast efforts and proposed many strategies to reduce DCF hepatotoxicity. In this regard, the present review provides a comparison and insight into recent developments in DCF through structural modification, drug delivery carriers (multiparticles, microparticles, and nanoparticles), and pharmacokinetics to reduce the toxicity side effects while simultaneously enhancing sustained drug release and the pharmaceutical effect. The researchers demonstrated that the nature and quantity of polymeric drug vehicles (hydrophilic or hydrophobic polymers) have a profound effect on DCF release rate, encapsulation efficiency, and mechanism of action. Furthermore, masking the DCF carboxylic acid with certain moieties such as hydrazones or heterocyclics could substantially boost the pharmaceutical and anticancer activities with a significant reduction in ulcerogenic effect. In this review, comparisons between the published DCF prodrugs, commercial formulations, and parent drug DCF based on the pharmacokinetics (the area under the concentration-time curve from dosing time 0 to infinity, time to reach the maximum concentration, and concentration of the agent inhibiting cell growth by 50%) were also elucidated. It also briefly summarizes the synergistic interactions between DCF with some bio-enhancers. In the last section, we highlighted how the researchers incorporated artificial intelligence during the drug formulation to overcome hepatotoxicity and used it to predict its activity against cancer cell lines. In the last line, this review will serve as compilation of useful and recent sources, which are indexed in Scopus, PubMed, Academic Search Complete, and others, on how scientists created more efficient and sustained release DCF formulations, and how they made it safer with almost no side effects.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] The anti-inflammatory drug Diclofenac retains anti-listerial activity in vivo
    Dutta, N. K.
    Mazumdar, K.
    Seok, S. H.
    Park, J. H.
    LETTERS IN APPLIED MICROBIOLOGY, 2008, 47 (02) : 106 - 111
  • [22] Novel Piperazine Derivatives as Potent Antihistamine, Anti-Inflammatory, and Anticancer Agents, their Synthesis and Characterization
    Mohammed, R. Ameer
    Shetty, Kannika K.
    Roy, Lairikyengbam Deepti
    Kumar, Jyotsna
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (14) : 1063 - 1073
  • [23] Synthesis of novel thiazoles bearing lupeol derivatives as potent anticancer and anti-inflammatory agents
    Narendar, Kummari
    Rao, B. Sambasiva
    Tirunavalli, Satyakrishna
    Jadav, Surender Singh
    Andugulapati, Sai Balaji
    Ramalingam, Vaikundamoorthy
    Babu, K. Suresh
    NATURAL PRODUCT RESEARCH, 2024, 38 (13) : 2207 - 2214
  • [24] A promising anti-inflammatory and anti-thrombotic drug for sepsis treatment
    Dong-Soon Im
    Archives of Pharmacal Research, 2011, 34
  • [26] Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives
    Aman, Farhana
    Hanif, Muhammad
    Siddiqui, Waseeq Ahmad
    Ashraf, Adnan
    Filak, Lukas K.
    Reynisson, Johannes
    Soehnel, Tilo
    Jamieson, Stephen M. F.
    Hartinger, Christian G.
    ORGANOMETALLICS, 2014, 33 (19) : 5546 - 5553
  • [27] REDUCTION OF ANTI-INFLAMMATORY DRUG COSTS WITH NEWER ASPIRIN FORMULATIONS
    HERSHEY, CO
    BROWN, A
    PORTER, DK
    MEDICAL CARE, 1985, 23 (08) : 998 - 1002
  • [28] Prophylactic effect of the anti-inflammatory drug diclofenac in experimental schistosomiasis mansoni
    Nessim, Nevine Guirguis
    Mahmoud, Soheir
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (02) : 161 - 165
  • [29] Need to Develop New Nonsteroidal Anti-Inflammatory Drug Formulations
    McCarberg, Bill
    Gibofsky, Allan
    CLINICAL THERAPEUTICS, 2012, 34 (09) : 1954 - 1963
  • [30] Degradation of anti-inflammatory drug diclofenac using cobalt ferrite as photocatalyst
    Gerbaldo, Maria Veronica
    Marchetti, Sergio Gustavo
    Elias, Veronica Rita
    Mendieta, Silvia Nazaret
    Crivello, Monica Elsie
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2021, 166 : 237 - 247